|

Algorand Price Prediction: ALGO kickstarts 38% correction

  • Algorand price has formed a bearish chart pattern, projecting a 38% correction on the horizon.
  • The bears could push ALGO to as low as $0.50 following a slice below a critical line of defense.
  • Algorand must revisit $0.94 in order to invalidate the bearish thesis

Algorand price has kickstarted a massive decline following the emergence of a bearish chart pattern. ALGO fell below a critical line of defense at $0.81, putting the pessimistic target on the radar. 

Algorand bears target $0.50 next

Algorand price has sliced below the lower boundary of the descending triangle pattern on the 12-hour chart, triggering a 38% collapse that could send ALGO lower toward $0.50, a bearish target given by the prevailing chart pattern.

The first line of defense for Algorand price is at the June 23 low at $0.71, then toward the June 21 low at $0.67. An additional increase in selling pressure may push ALGO lower toward the 127.2% Fibonacci extension level at $0.62.

A spike in bearish sentiment may continue to drive Algorand price to reach the pessimistic target at $0.50, resulting in a 38% drop from the lower boundary of the governing technical pattern.

However, if the bulls come to the rescue, Algorand price may target the downside trend line of the descending triangle pattern at $0.81, before attempting to reach the 21 twelve-hour Simple Moving Average (SMA) at $0.89, which coincides with the 78.6% Fibonacci retracement level.

An additional surge in buy orders may see Algorand price reach the 50 twelve-hour SMA at $0.94, intersecting with the upper boundary of the prevailing chart pattern.

ALGO

ALGO/USDT 12-hour chart

If Algorand price slices above the topside trend line of the governing technical pattern, the bearish narrative may be invalidated.

Algorand price may continue to move higher, targeting the 50% retracement level at $1.05 next, where the resistance line is given by the Momentum Reversal Indicator (MRI) also sits. 

Bigger aspirations will target the 38.2% Fibonacci retracement level at $1.11, intersecting with the 100 twelve-hour SMA. 

Author

Sarah Tran

Sarah Tran

Independent Analyst

Sarah has closely followed the growth of blockchain technology and its adoption since 2016.

More from Sarah Tran
Share:

Editor's Picks

XRP pressured by weak ETF flows and declining retail interest

Ripple (XRP) is edging lower, trading above its intraday low of $1.32 at the time of writing on Tuesday. The decline from its weekly opening of $1.39 reflects heightened volatility in the broader cryptocurrency market, accentuated by tariff-triggered uncertainty.

Crypto Today: Bitcoin, Ethereum, XRP come under renewed pressure amid ETF outflows, tariff uncertainty

Bitcoin, Ethereum and Ripple are trading under increasing selling pressure at the time of writing on Tuesday, as market participants navigate renewed tariff uncertainty. The Crypto King holds above $63,000, down 2% intraday from its $64,656 open.

Bitcoin falls to two-week low as ETF outflows, tariff chaos weigh

Bitcoin price extends losses on Tuesday, ending a two-week consolidation phase. Risk-on sentiment fades amid growing uncertainty over Trump’s tariffs and rising US-Iran tensions, increasing downside risks toward $60,000.

Sui Price Forecast: SUI capitulates under pressure, opens the door to $0.70

Sui (SUI) declines by 3% at press time on Tuesday, extending the downside breakout of a short-consolidation range confirmed the previous day. Retail sentiment is bearish, as evidenced by increased long liquidations and a sharp drop in the funding rate. 

Bitcoin Price Annual Forecast: BTC holds long-term bullish structure heading into 2026

Bitcoin (BTC) is wrapping up 2025 as one of its most eventful years, defined by unprecedented institutional participation, major regulatory developments, and extreme price volatility.

Bitcoin: No recovery in sight

Bitcoin (BTC) price continues to trade within a range-bound zone, hovering around $67,000 at the time of writing on Friday, and falling slightly so far this week, with no signs of recovery.